ARCHIVES

Risk-Benefit Analysis Advised Prior To Hormone Therapy

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: UCSD Recruits Mitchell From USC; Wade Wins Policy Fellowship; ASCO Honors Burchenal

July 15, 1994

DCE Recompetition Of Human Tissue Procurement Approved

November 23, 1990

Arzerra Given Accelerated Approval For Leukemia

October 30, 2009

In Brief: Oliverio Moves to DEA; Kushner Blass NIH Slow Pay; DeVita Welcomes Hawkin’s Probe

February 6, 1981

In Brief: Walter Lawrence, Reginald Ho Lead ACS; Henderson To Leave Dana-Farber for UCSF

November 22, 1991

Cancer Advocacy: Jay Hedlund Resigns As NPCC President

May 14, 1999